45 results
8-K/A
EX-99.3
CRVO
CervoMed Inc
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
ability to hire, retain and appropriately incentivize qualified individuals, generate sufficient sales leads, provide adequate training to sales … class protected by applicable law, and our recruitment, hiring, development, training, compensation, and advancement practices are based
8-K/A
EX-99.2
zgxsss0uaok4h
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
et8hkz5z nw
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
424B3
a9tsyw4gg176
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
9xa5r
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
vxgvvz36rd7pn4
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
EX-2.1
141qz
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-2.1
iv7gfhmqh0jr
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-99.1
5z2kzeihp09l2g3s
13 Sep 21
Diffusion Pharmaceuticals Issues Letter to Shareholders
4:09pm
8-K
EX-99.1
lwok7r 6h
11 May 20
Diffusion Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
4:58pm
8-K
EX-99.1
vul8gk1mk3gsgq01n6wg
24 Mar 20
Diffusion Pharmaceuticals Anticipates Enrollment in its Ambulance-based Stroke Trial Will be Slowed Due to the Impact of the Coronavirus
4:41pm